Selected research
Market Outlook & Growth Opportunities
Global Isosorbide Mononitrate Tablet Market Outlook and Growth Opportunities 2026
Market perspective
The global Isosorbide Mononitrate Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Isosorbide Mononitrate Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Isosorbide Mononitrate Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Isosorbide Mononitrate Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Isosorbide Mononitrate Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Isosorbide Mononitrate Tablet market include Lotus Pharmaceuticals, Recipeharm, Cisen, Keyuan Pharmaceutical, Lunan Pharmaceutical Group, Qilu Pharma, Ruiyang Pharmaceutical and Yikang Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Isosorbide Mononitrate Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Isosorbide Mononitrate Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Isosorbide Mononitrate Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isosorbide Mononitrate Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.
Isosorbide Mononitrate Tablet Segment by Company
Lotus Pharmaceuticals
Recipeharm
Cisen
Keyuan Pharmaceutical
Lunan Pharmaceutical Group
Qilu Pharma
Ruiyang Pharmaceutical
Yikang Pharmaceutical
Isosorbide Mononitrate Tablet Segment by Type
10mg
20mg
Other
Isosorbide Mononitrate Tablet Segment by Application
Hospital
Clinic
Other
Isosorbide Mononitrate Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Isosorbide Mononitrate Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Isosorbide Mononitrate Tablet market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Isosorbide Mononitrate Tablet significant trends, drivers, influence factors in global and regions.
6. To analyze Isosorbide Mononitrate Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isosorbide Mononitrate Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isosorbide Mononitrate Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isosorbide Mononitrate Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Isosorbide Mononitrate Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isosorbide Mononitrate Tablet industry.
Chapter 3: Detailed analysis of Isosorbide Mononitrate Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Isosorbide Mononitrate Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Isosorbide Mononitrate Tablet in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg
- 20mg
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Lotus Pharmaceuticals
- Recipeharm
- Cisen
- Keyuan Pharmaceutical
- Lunan Pharmaceutical Group
- Qilu Pharma
- Ruiyang Pharmaceutical
- Yikang Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Isosorbide Mononitrate Tablet Sales Value (2021-2032)
- 1.2.2 Global Isosorbide Mononitrate Tablet Sales Volume (2021-2032)
- 1.2.3 Global Isosorbide Mononitrate Tablet Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Isosorbide Mononitrate Tablet Market Dynamics
- 2.1 Isosorbide Mononitrate Tablet Industry Trends
- 2.2 Isosorbide Mononitrate Tablet Industry Drivers
- 2.3 Isosorbide Mononitrate Tablet Industry Opportunities and Challenges
- 2.4 Isosorbide Mononitrate Tablet Industry Restraints
3 Isosorbide Mononitrate Tablet Market by Company
- 3.1 Global Isosorbide Mononitrate Tablet Company Revenue Ranking in 2025
- 3.2 Global Isosorbide Mononitrate Tablet Revenue by Company (2021-2026)
- 3.3 Global Isosorbide Mononitrate Tablet Sales Volume by Company (2021-2026)
- 3.4 Global Isosorbide Mononitrate Tablet Average Price by Company (2021-2026)
- 3.5 Global Isosorbide Mononitrate Tablet Company Ranking (2024-2026)
- 3.6 Global Isosorbide Mononitrate Tablet Company Manufacturing Base and Headquarters
- 3.7 Global Isosorbide Mononitrate Tablet Company Product Type and Application
- 3.8 Global Isosorbide Mononitrate Tablet Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Isosorbide Mononitrate Tablet Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Isosorbide Mononitrate Tablet Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Isosorbide Mononitrate Tablet Market by Type
- 4.1 Isosorbide Mononitrate Tablet Type Introduction
- 4.1.1 10mg
- 4.1.2 20mg
- 4.1.3 Other
- 4.2 Global Isosorbide Mononitrate Tablet Sales Volume by Type
- 4.2.1 Global Isosorbide Mononitrate Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Isosorbide Mononitrate Tablet Sales Volume by Type (2021-2032)
- 4.2.3 Global Isosorbide Mononitrate Tablet Sales Volume Share by Type (2021-2032)
- 4.3 Global Isosorbide Mononitrate Tablet Sales Value by Type
- 4.3.1 Global Isosorbide Mononitrate Tablet Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Isosorbide Mononitrate Tablet Sales Value by Type (2021-2032)
- 4.3.3 Global Isosorbide Mononitrate Tablet Sales Value Share by Type (2021-2032)
5 Isosorbide Mononitrate Tablet Market by Application
- 5.1 Isosorbide Mononitrate Tablet Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Isosorbide Mononitrate Tablet Sales Volume by Application
- 5.2.1 Global Isosorbide Mononitrate Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Isosorbide Mononitrate Tablet Sales Volume by Application (2021-2032)
- 5.2.3 Global Isosorbide Mononitrate Tablet Sales Volume Share by Application (2021-2032)
- 5.3 Global Isosorbide Mononitrate Tablet Sales Value by Application
- 5.3.1 Global Isosorbide Mononitrate Tablet Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Isosorbide Mononitrate Tablet Sales Value by Application (2021-2032)
- 5.3.3 Global Isosorbide Mononitrate Tablet Sales Value Share by Application (2021-2032)
6 Isosorbide Mononitrate Tablet Regional Sales and Value Analysis
- 6.1 Global Isosorbide Mononitrate Tablet Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Isosorbide Mononitrate Tablet Sales by Region (2021-2032)
- 6.2.1 Global Isosorbide Mononitrate Tablet Sales by Region: 2021-2026
- 6.2.2 Global Isosorbide Mononitrate Tablet Sales by Region (2027-2032)
- 6.3 Global Isosorbide Mononitrate Tablet Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Isosorbide Mononitrate Tablet Sales Value by Region (2021-2032)
- 6.4.1 Global Isosorbide Mononitrate Tablet Sales Value by Region: 2021-2026
- 6.4.2 Global Isosorbide Mononitrate Tablet Sales Value by Region (2027-2032)
- 6.5 Global Isosorbide Mononitrate Tablet Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Isosorbide Mononitrate Tablet Sales Value (2021-2032)
- 6.6.2 North America Isosorbide Mononitrate Tablet Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Isosorbide Mononitrate Tablet Sales Value (2021-2032)
- 6.7.2 Europe Isosorbide Mononitrate Tablet Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Isosorbide Mononitrate Tablet Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Isosorbide Mononitrate Tablet Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Isosorbide Mononitrate Tablet Sales Value (2021-2032)
- 6.9.2 South America Isosorbide Mononitrate Tablet Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Isosorbide Mononitrate Tablet Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Isosorbide Mononitrate Tablet Sales Value Share by Country, 2025 VS 2032
7 Isosorbide Mononitrate Tablet Country-level Sales and Value Analysis
- 7.1 Global Isosorbide Mononitrate Tablet Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Isosorbide Mononitrate Tablet Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Isosorbide Mononitrate Tablet Sales by Country (2021-2032)
- 7.3.1 Global Isosorbide Mononitrate Tablet Sales by Country (2021-2026)
- 7.3.2 Global Isosorbide Mononitrate Tablet Sales by Country (2027-2032)
- 7.4 Global Isosorbide Mononitrate Tablet Sales Value by Country (2021-2032)
- 7.4.1 Global Isosorbide Mononitrate Tablet Sales Value by Country (2021-2026)
- 7.4.2 Global Isosorbide Mononitrate Tablet Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.9.2 France Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.16.2 China Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.19.2 India Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Isosorbide Mononitrate Tablet Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Isosorbide Mononitrate Tablet Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Isosorbide Mononitrate Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Lotus Pharmaceuticals
- 8.1.1 Lotus Pharmaceuticals Company Information
- 8.1.2 Lotus Pharmaceuticals Business Overview
- 8.1.3 Lotus Pharmaceuticals Isosorbide Mononitrate Tablet Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Lotus Pharmaceuticals Isosorbide Mononitrate Tablet Product Portfolio
- 8.1.5 Lotus Pharmaceuticals Recent Developments
- 8.2 Recipeharm
- 8.2.1 Recipeharm Company Information
- 8.2.2 Recipeharm Business Overview
- 8.2.3 Recipeharm Isosorbide Mononitrate Tablet Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Recipeharm Isosorbide Mononitrate Tablet Product Portfolio
- 8.2.5 Recipeharm Recent Developments
- 8.3 Cisen
- 8.3.1 Cisen Company Information
- 8.3.2 Cisen Business Overview
- 8.3.3 Cisen Isosorbide Mononitrate Tablet Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Cisen Isosorbide Mononitrate Tablet Product Portfolio
- 8.3.5 Cisen Recent Developments
- 8.4 Keyuan Pharmaceutical
- 8.4.1 Keyuan Pharmaceutical Company Information
- 8.4.2 Keyuan Pharmaceutical Business Overview
- 8.4.3 Keyuan Pharmaceutical Isosorbide Mononitrate Tablet Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Keyuan Pharmaceutical Isosorbide Mononitrate Tablet Product Portfolio
- 8.4.5 Keyuan Pharmaceutical Recent Developments
- 8.5 Lunan Pharmaceutical Group
- 8.5.1 Lunan Pharmaceutical Group Company Information
- 8.5.2 Lunan Pharmaceutical Group Business Overview
- 8.5.3 Lunan Pharmaceutical Group Isosorbide Mononitrate Tablet Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Lunan Pharmaceutical Group Isosorbide Mononitrate Tablet Product Portfolio
- 8.5.5 Lunan Pharmaceutical Group Recent Developments
- 8.6 Qilu Pharma
- 8.6.1 Qilu Pharma Company Information
- 8.6.2 Qilu Pharma Business Overview
- 8.6.3 Qilu Pharma Isosorbide Mononitrate Tablet Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Qilu Pharma Isosorbide Mononitrate Tablet Product Portfolio
- 8.6.5 Qilu Pharma Recent Developments
- 8.7 Ruiyang Pharmaceutical
- 8.7.1 Ruiyang Pharmaceutical Company Information
- 8.7.2 Ruiyang Pharmaceutical Business Overview
- 8.7.3 Ruiyang Pharmaceutical Isosorbide Mononitrate Tablet Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Ruiyang Pharmaceutical Isosorbide Mononitrate Tablet Product Portfolio
- 8.7.5 Ruiyang Pharmaceutical Recent Developments
- 8.8 Yikang Pharmaceutical
- 8.8.1 Yikang Pharmaceutical Company Information
- 8.8.2 Yikang Pharmaceutical Business Overview
- 8.8.3 Yikang Pharmaceutical Isosorbide Mononitrate Tablet Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Yikang Pharmaceutical Isosorbide Mononitrate Tablet Product Portfolio
- 8.8.5 Yikang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Isosorbide Mononitrate Tablet Value Chain Analysis
- 9.1.1 Isosorbide Mononitrate Tablet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Isosorbide Mononitrate Tablet Sales Mode & Process
- 9.2 Isosorbide Mononitrate Tablet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Isosorbide Mononitrate Tablet Distributors
- 9.2.3 Isosorbide Mononitrate Tablet Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst